Contacts

Dr. Christian Traichel

Partner

Read More

Dr Bert Kimpel

Partner

Read More

Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt

Partner

Read More

Dr. Manja Epping

Partner

Read More
Contacts

Dr. Christian Traichel

Partner

Read More

Dr Bert Kimpel

Partner

Read More

Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt

Partner

Read More

Dr. Manja Epping

Partner

Read More

14 January 2013

Taylor Wessing advises SBI Holdings on the acquisition of shares in Photonamic

SBI Holdings, Inc. (“SBIH”), Tokyo, Japan, has indirectly acquired a 20% stake in Photonamic GmbH & Co. KG (“Photonamic”), seated in Wedel, Germany, from the financial investors Martin and Matthias Nixdorf. Photonamic is a subsidiary of the German pharmaceutical company medac GmbH, seated in Hamburg. The equity acquisition is to make Photonamic a joint venture between SBIH and medac. Capitalizing on this, Photonamic is expected to cooperate with SBI Pharmaceuticals Co., Ltd., a drug company engaged in biotechnology under the umbrella of the SBI Group.

About Photonamic
Photonamic is engaged in research and development of drugs under the umbrella of medac that manufactures and sells an intraoperative diagnostic drug for brain tumors in Europe. 

About SBI Group
SBI Group is a financial conglomerate extensively developing two principal segments that are (1) Asset Management Business and (2) Financial Services Business including brokerage and investment banking, commercial banking, and insurance. In addition to the above financial areas, SBIH, regarding the biotechnology-related business as the largest growth field of the SBI Group, is accelerating operations in Japan and abroad. Taking advantage of this investment in Photonamic, SBI Group will further accelerate operations in Europe, while continuously establishing a global business structure. 

Advisor SBI Holdings
Taylor Wessing: Dr. Christian Traichel (Leadpartner, Corporate/M&A, Munich), Dr. Bert Kimpel (Partner, Tax, Dusseldorf), Dr. Marco Hartmann-Rüppel (Partner, Merger Control, Hamburg), Dr. Manja Epping (Partner, Life Sciences & Healthcare, Munich), Dr. Arno Brokamp LL.M (Associate, Corporate/M&A, Munich), Dr. Philipp Ludewig (Associate, Merger control, Hamburg).
 
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Skyline view of traffic
Corporate/M&A & capital markets

Taylor Wessing advises Hardinge, Inc. on the acquisition of WEISSER Group

21 July 2021

by multiple authors

Click here to find out more
Inside the Office Building
Corporate/M&A & capital markets

LiDAR for autonomous driving: Taylor Wessing advises Ibeo on participation by AAC Technologies

LiDAR for autonomous driving: Taylor Wessing advises Ibeo on participation by AAC Technologies

17 June 2021

by multiple authors

Click here to find out more
Close-Up Of Modern Office Facade
Corporate/M&A & capital markets

Taylor Wessing advises ebm-papst on the sale of a majority stake in IKOR group to Belgian Connect Group

30 April 2021

by multiple authors

Click here to find out more